Markets Maxim cuts Can-Fite Biopharma to hold; removes PT Maxim Group downgraded Can-Fite Biopharma (NYSE American:CANF) to “hold” from “buy” and removed its previous $7 price target after the company announced a $5-million registered direct offering. The stock was quoted at... March 9, 2018